Detalhe da pesquisa
1.
The role of hyperthermic intraperitoneal chemotherapy using paclitaxel in platinum-sensitive recurrent epithelial ovarian cancer patients with microscopic residual disease after cytoreduction.
Ann Surg Oncol
; 22(3): 987-93, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25212832
2.
HIPEC in ovarian cancer: treatment of a new era or is it the end of the pipeline?
Gynecol Oncol
; 139(2): 363-8, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26091936
3.
Treatment of microscopic disease with hyperthermic intraoperative intraperitoneal chemotherapy after complete cytoreduction improves disease-free survival in patients with stage IIIC/IV ovarian cancer.
Ann Surg Oncol
; 21(7): 2383-9, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24599409
4.
Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue.
Eur J Radiol
; 85(10): 1824-1828, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27666623
5.
Morbidity and mortality outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients aged 75 years and over: Spanish group of peritoneal cancer surgery (GECOP) multicenter study.
Surg Oncol
; 25(2): 111-6, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27312037
6.
Cytoreduction and HIPEC after neoadjuvant chemotherapy in stage IIIC-IV ovarian cancer. Critical analysis in elderly patients.
Eur J Obstet Gynecol Reprod Biol
; 179: 88-93, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24965986